We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERP
251
DELISTED
TerraForm Power, Inc
TERP
$1.69M 0.01%
117,996
+58,946
+100% +$809K
TMO icon
252
Thermo Fisher Scientific
TMO
$211B
$1.66M 0.01%
5,651
-1,147
-17% -$316K
PRNB
253
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$1.66M 0.01%
+49,950
New +$1.56M
YMAB
254
DELISTED
Y-mAbs Therapeutics
YMAB
$1.64M 0.01%
+71,575
New +$1.64M
WELL icon
255
Welltower
WELL
$178B
$1.63M 0.01%
19,984
-1,232
-6% -$96.8K
SA
256
Seabridge Gold
SA
$2.8B
$1.61M 0.01%
118,835
-13,293
-10% -$158K
V icon
257
Visa
V
$677B
$1.61M 0.01%
9,259
+5,140
+125% +$842K
RYTM icon
258
Rhythm Pharmaceuticals
RYTM
$7B
$1.59M 0.01%
72,070
-11,045
-13% -$279K
KURA icon
259
Kura Oncology
KURA
$922M
$1.57M 0.01%
79,928
-11,945
-13% -$198K
URGN icon
260
UroGen Pharma
URGN
$2B
$1.56M 0.01%
43,459
-4,271
-9% -$157K
ABT icon
261
Abbott
ABT
$180B
$1.52M 0.01%
18,052
-3,988
-18% -$314K
KSS icon
262
Kohl's
KSS
$2.03B
$1.48M 0.01%
31,055
+3,263
+12% +$197K
DAN icon
263
Dana Inc
DAN
$2.91B
$1.46M 0.01%
73,228
+3,485
+5% +$62K
AVB icon
264
AvalonBay Communities
AVB
$27.1B
$1.46M 0.01%
7,167
-639
-8% -$129K
EQR icon
265
Equity Residential
EQR
$25.4B
$1.45M 0.01%
19,136
-1,658
-8% -$127K
MPC icon
266
Marathon Petroleum
MPC
$90.3B
$1.45M 0.01%
25,865
+1,999
+8% +$109K
FOXF icon
267
Fox Factory Holding Corp
FOXF
$776M
$1.44M 0.01%
17,429
-2,273
-12% -$169K
NATI
268
DELISTED
National Instruments Corp
NATI
$1.43M 0.01%
33,997
+3,152
+10% +$134K
UNP icon
269
Union Pacific
UNP
$183B
$1.41M 0.01%
8,347
-1,040
-11% -$178K
MA icon
270
Mastercard
MA
$477B
$1.41M 0.01%
5,319
+2,575
+94% +$644K
DD icon
271
DuPont de Nemours
DD
$18.6B
$1.4M 0.01%
+14,799
New +$1.77M
MANH icon
272
Manhattan Associates
MANH
$8.97B
$1.38M 0.01%
19,941
-6,453
-24% -$415K
PYPL icon
273
PayPal
PYPL
$49.5B
$1.38M 0.01%
12,049
+5,727
+91% +$635K
HUBB icon
274
Hubbell
HUBB
$25.7B
$1.35M 0.01%
10,320
-38
-0.4% -$4.69K
TPIC
275
DELISTED
TPI Composites
TPIC
$1.34M 0.01%
54,042
+29,781
+123% +$762K

Similar funds

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.